150 related articles for article (PubMed ID: 7227446)
21. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
Vaughn CB; Panettiere F; Thigpen T; Bottomley R; Hoogstraten B; Samal B
Cancer Treat Rep; 1981; 65(5-6):443-5. PubMed ID: 7237465
[No Abstract] [Full Text] [Related]
22. [Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
Goldhirsch A; Joss R; Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
Dtsch Med Wochenschr; 1981 Aug; 106(35):1105-9. PubMed ID: 6266800
[No Abstract] [Full Text] [Related]
23. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
[No Abstract] [Full Text] [Related]
24. Etoposide salvage therapy for refractory germ cell tumors: an update.
Williams SD; Einhorn LH
Cancer Treat Rev; 1982 Jun; 9 Suppl():67-71. PubMed ID: 6290056
[No Abstract] [Full Text] [Related]
25. Reversal of recurrent laryngeal nerve palsy following VP16-213 combination therapy in a patient with metastatic teratoma of the testis.
Rubery ED
Cancer Chemother Pharmacol; 1982; 7(2-3):219-21. PubMed ID: 6177438
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: an analysis.
D'Aoust JC; Prestayko AW; Einhorn LH; Comis RL; Ginsberg SJ; Archambault WA; Crooke ST
Med Pediatr Oncol; 1979; 6(3):195-205. PubMed ID: 89624
[TBL] [Abstract][Full Text] [Related]
27. [Chemotherapy of malignant testicular germ cell tumors: current state in children and adults].
Göbel U; Weissbach L
Klin Padiatr; 1983; 195(3):190-5. PubMed ID: 6192279
[TBL] [Abstract][Full Text] [Related]
28. Etoposide (VP-16-213). Current status of an active anticancer drug.
O'Dwyer PJ; Leyland-Jones B; Alonso MT; Marsoni S; Wittes RE
N Engl J Med; 1985 Mar; 312(11):692-700. PubMed ID: 2983208
[No Abstract] [Full Text] [Related]
29. Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.
Schell FC; Yap HY; Hortobagyi GN; Issell B; Esparza L
Cancer Chemother Pharmacol; 1982; 7(2-3):223-5. PubMed ID: 7083463
[No Abstract] [Full Text] [Related]
30. Etoposide (VP 16-213; VePesid).
Med Lett Drugs Ther; 1984 May; 26(661):48-9. PubMed ID: 6325855
[No Abstract] [Full Text] [Related]
31. Chemotherapy of refractory germ cell cancer with Etoposide.
Lederman GS; Garnick MB; Canellos GP; Richie JP
J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675
[TBL] [Abstract][Full Text] [Related]
32. VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms.
Mortimer J; Bukowski RM; Montie J; Hewlett JS; Livingston RB
Cancer Chemother Pharmacol; 1982; 7(2-3):215-8. PubMed ID: 6282486
[TBL] [Abstract][Full Text] [Related]
33. [Salvage chemotherapy of far advanced testicular cancer with VP-16 and CDDP].
Gotoh S; Fukui I; Kasamatsu T; Nagahama K; Kitahara S; Kihara K; Takeuchi S; Higashi Y; Ohshima H; Nagamatsu H
Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):732-7. PubMed ID: 3226023
[No Abstract] [Full Text] [Related]
34. Does etoposide have curative potential?
Ignoffo RJ
Clin Pharm; 1983; 2(2):167. PubMed ID: 6309470
[No Abstract] [Full Text] [Related]
35. Phase II clinical trial of VP-16-213 in ovarian cancer.
Maskens AP; Armand JP; Lacave AJ; De Jager RL; Hansen HH; Wolff JP
Cancer Treat Rep; 1981; 65(3-4):329-30. PubMed ID: 7016320
[No Abstract] [Full Text] [Related]
36. [Chemotherapy of testicular tumors. II. Effect of cadmium chloride on testicular tumors].
Sakatoku J; Ebisuta K; Yoshida O; Kawamura J
Hinyokika Kiyo; 1968 Feb; 14(2):115-26. PubMed ID: 5692621
[No Abstract] [Full Text] [Related]
37. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
[No Abstract] [Full Text] [Related]
38. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
Konishi I; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122
[TBL] [Abstract][Full Text] [Related]
39. Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Am J Obstet Gynecol; 1984 Dec; 150(8):924-7. PubMed ID: 6095666
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Radice PA; Bunn PA; Ihde DC
Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]